Evidence map›Paper›PMID 20674814›Full record

ReviewBiochimica et biophysica acta2011

Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.

Ashok N Hegde, Sudarshan C Upadhya

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Regulation of Phosphorylated State of NMDA Receptor by STEPAntioxidants (Basel, Switzerland) · 2021
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis.International journal of molecular sciences · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ashok N HegdeDepartment of Neurology and Anatomy, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA. ahegde@wfubmc.edu
Sudarshan C Upadhya
Wake Forest University · US

Funding

REGULATED PROTEOLYSIS AND LONG-TERM MEMORYR01MH060225 · NIMH · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HEGDE, ASHOK N · 2000 to 2010
$2.4M
Local Mechanisms Underlying Synaptic PlasticityR01NS066583 · NINDS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HEGDE, ASHOK N · 2009 to 2012
$1.3M
NIMH NIH HHS MH060225NIMH NIH HHS R01 MH060225NINDS NIH HHS NS066583NINDS NIH HHS R01 NS066583
6 · The paper itself

Abstract

Proteolysis by the ubiquitin-proteasome pathway (UPP) is now widely recognized as a molecular mechanism controlling myriad normal functions in the nervous system. Also, this pathway is intimately linked to many diseases and disorders of the brain. Among the diseases connected to the UPP are neurodegenerative disorders such as Alzheimer's, Parkinson's and Huntington's diseases. Perturbation in the UPP is also believed to play a causative role in mental disorders such as Angelman syndrome. The pathology of neurodegenerative diseases is characterized by abnormal deposition of insoluble protein aggregates or inclusion bodies within neurons. The ubiquitinated protein aggregates are believed to result from dysfunction of the UPP or from structural changes in the protein substrates which prevent their recognition and degradation by the UPP. An early effect of abnormal UPP in diseases of the nervous system is likely to be impairment of synaptic function. Here we discuss the UPP and its physiological roles in the nervous system and how alterations in the UPP relate to development of nervous system diseases. This article is part of a Special Issue entitled The 26S Proteasome: When degradation is just not enough!

Indexed as

Protein Processing, Post-TranslationalAnimalsHumansModels, BiologicalNervous System DiseasesProteasome Endopeptidase ComplexSignal TransductionUbiquitinProteasome Endopeptidase ComplexUbiquitin

Identifiers

PMID20674814
PMCPMC2995838
OpenAlexW2034012303

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.